We are live on ! Find out more
GKIM

GW&K Investment Management Portfolio holdings

AUM $11.3B
1-Year Est. Return 31.98%
This Fund
S&P 500
This Quarter Est. Return
+11.66%
1 Year Est. Return
+31.98%
3 Year Est. Return
+79.76%
5 Year Est. Return
+101.81%
10 Year Est. Return
+512.72%
AUM
$9.86B
AUM Growth
+$800M
Cap. Flow
-$8.88M
Cap. Flow %
-0.09%
Top 10 Hldgs %
12.23%
Holding
511
New
112
Increased
96
Reduced
240
Closed
20

Top Buys

Rank Stock Value
1
CYBR
CyberArk
CYBR
+$64.2M
2
SM icon
SM Energy
SM
+$41.9M
3
ATKR icon
Atkore
ATKR
+$41.3M
4
OVV icon
Ovintiv
OVV
+$39.3M
5
MKTX icon
MarketAxess Holdings
MKTX
+$31.5M

Top Sells

Rank Stock Value
1
RBA icon
RB Global
RBA
+$94.3M
2
IT icon
Gartner
IT
+$89.1M
3
FANG icon
Diamondback Energy
FANG
+$81.5M
4
PCTY icon
Paylocity
PCTY
+$35.6M
5
CCXI
ChemoCentryx, Inc.
CCXI
+$35.3M

Sector Composition

Rank Sector Weight
1 Healthcare 17.78%
2 Industrials 16.63%
3 Technology 14.81%
4 Financials 12.85%
5 Consumer Discretionary 11.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFGC icon
1
Performance Food Group
PFGC
$17.9B
$144M 1.46%
2,472,015
-40,685
-2% -$2.22M
RBC icon
2
RBC Bearings
RBC
$18B
$140M 1.42%
669,850
-10,279
-2% -$2.35M
FIVE icon
3
Five Below
FIVE
$13B
$131M 1.33%
739,601
-13,913
-2% -$2.19M
GMED icon
4
Globus Medical
GMED
$11.1B
$127M 1.29%
1,712,151
+135,935
+9% +$9.26M
TXRH icon
5
Texas Roadhouse
TXRH
$13.7B
$121M 1.23%
1,334,932
-21,576
-2% -$2.07M
BAH icon
6
Booz Allen Hamilton
BAH
$8.92B
$119M 1.21%
1,140,392
-17,125
-1% -$1.78M
HALO icon
7
Halozyme
HALO
$11.7B
$119M 1.21%
2,088,856
-114,186
-5% -$5.85M
MSFT icon
8
Microsoft
MSFT
$3.75T
$110M 1.11%
458,065
-15,630
-3% -$3.75M
HZNP
9
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$100M 1.01%
879,328
-10,024
-1% -$833K
SLAB icon
10
Silicon Laboratories
SLAB
$7.22B
$94M 0.95%
692,539
-11,199
-2% -$1.47M
LOPE icon
11
Grand Canyon Education
LOPE
$3.91B
$91.6M 0.93%
867,357
-12,275
-1% -$1.22M
MGY icon
12
Magnolia Oil & Gas
MGY
$5.84B
$90.5M 0.92%
3,861,197
-55,979
-1% -$1.36M
IDA icon
13
Idacorp
IDA
$8.15B
$88.6M 0.9%
821,659
-15,080
-2% -$1.56M
UNH icon
14
UnitedHealth
UNH
$368B
$87.6M 0.89%
165,276
-3,108
-2% -$1.65M
ADC icon
15
Agree Realty
ADC
$9.49B
$83.9M 0.85%
1,183,251
-18,310
-2% -$1.26M
LAD icon
16
Lithia Motors
LAD
$8.23B
$83.7M 0.85%
408,802
-7,366
-2% -$1.57M
MANH icon
17
Manhattan Associates
MANH
$11.1B
$82.2M 0.83%
677,341
-24,975
-4% -$3.07M
BJ icon
18
BJs Wholesale Club
BJ
$12.4B
$80.9M 0.82%
1,222,549
-82,354
-6% -$5.97M
ITCI
19
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$76.8M 0.78%
1,450,382
-15,453
-1% -$774K
IR icon
20
Ingersoll Rand
IR
$34.4B
$76.2M 0.77%
1,457,728
+119,820
+9% +$6.12M
MTDR icon
21
Matador Resources
MTDR
$5.98B
$76.1M 0.77%
1,328,785
-17,050
-1% -$1.08M
PNFP icon
22
Pinnacle Financial Partners Inc
PNFP
$16B
$74.2M 0.75%
1,010,649
-22,487
-2% -$1.81M
ATKR icon
23
Atkore
ATKR
$3.17B
$73.5M 0.75%
647,776
+394,908
+156% +$41.3M
NDSN icon
24
Nordson
NDSN
$17.3B
$70.8M 0.72%
297,692
-7,007
-2% -$1.6M
NBIX icon
25
Neurocrine Biosciences
NBIX
$16.6B
$68.6M 0.7%
574,542
-20,786
-3% -$2.43M

Similar funds

GW&K Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, GW&K Investment Management held 511 positions worth $9.86B, up 8.8% from $9.06B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

GW&K Investment Management's Q4 2022 filing shows 112 new, 96 increased, 240 reduced and 20 closed positions. Its largest new stake was CyberArk: 444,305 shares worth $57.6M. The largest sale was RB Global, an estimated $94.3M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Industrials and Technology.

  • GW&K Investment Management's largest Q4 2022 buy was CyberArk: 444,305 shares worth $57.6M.
  • GW&K Investment Management added most to SM Energy in Q4 2022, an estimated $41.9M increase.
  • GW&K Investment Management's biggest Q4 2022 reduction was RB Global, cutting an estimated $94.3M.
  • GW&K Investment Management fully exited ChemoCentryx, Inc. in Q4 2022, selling an estimated $35.3M.
  • GW&K Investment Management's ten largest holdings make up 12% of its $9.86B portfolio in Q4 2022.
  • GW&K Investment Management opened 112 new positions and closed 20 in Q4 2022.
  • GW&K Investment Management's portfolio value rose 8.8% quarter-over-quarter to $9.86B.

Based on GW&K Investment Management's 13F filing for Q4 2022, filed 10 Feb 2023.